Tiny Actors in the Big Cellular World: Extracellular Vesicles Playing Critical Roles in Cancer.
Communications among cells can be achieved either via direct interactions or via secretion of soluble factors. The emergence of extracellular vesicles (EVs) as entities that play key roles in cell-to-cell communication offer opportunities in exploring their features for use in therapeutics; i.e., management and treatment of various pathologies, such as those used for cancer. The potential use of EVs as therapeutic agents is attributed not only for their cell membrane-bound components, but also for their cargos, mostly bioactive molecules, wherein the former regulate interactions with a recipient cell while the latter trigger cellular functions/molecular mechanisms of a recipient cell. In this article, we highlight the involvement of EVs in hallmarks of a cancer cell, particularly focusing on those molecular processes that are influenced by EV cargos. Moreover, we explored the roles of RNA species and proteins carried by EVs in eliciting drug resistance phenotypes. Interestingly, engineered EVs have been investigated and proposed as therapeutic agents in various in vivo and in vitro studies, as well as in several clinical trials.
['Jurj|Ancuta|A|', 'Pop-Bica|Cecilia|C|', 'Slaby|Ondrej|O|', 'Ştefan|Cristina D|CD|', 'Cho|William C|WC|0000-0003-4174-4586', 'Korban|Schuyler S|SS|0000-0003-1544-5160', 'Berindan-Neagoe|Ioana|I|0000-0001-5828-1325']
D000818:Animals D002450:Cell Communication D016503:Drug Delivery Systems D000067128:Extracellular Vesicles D006801:Humans D009369:Neoplasms
extracellular vesicles cancer cell-to-cell communication therapeutic agents